NYSE:FTV - Fortive Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $78.33
  • Forecasted Upside: 42.63 %
  • Number of Analysts: 11
  • Breakdown:
  • 0 Sell Ratings
  • 6 Hold Ratings
  • 5 Buy Ratings
  • 0 Strong Buy Ratings
$54.92
▲ +0.05 (0.09%)

This chart shows the closing price for FTV by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Fortive Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for FTV and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for FTV

Analyst Price Target is $78.33
▲ +42.63% Upside Potential
This price target is based on 11 analysts offering 12 month price targets for Fortive in the last 3 months. The average price target is $78.33, with a high forecast of $0.00 and a low forecast of $0.00. The average price target represents a 42.63% upside from the last price of $54.92.

This chart shows the closing price for FTV for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 11 polled investment analysts is to hold stock in Fortive. This rating has held steady since May 2022, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 9 buy ratings
  • 6 hold ratings
  • 0 sell ratings
1/11/2021
  • 0 strong buy ratings
  • 9 buy ratings
  • 4 hold ratings
  • 0 sell ratings
4/11/2021
  • 0 strong buy ratings
  • 8 buy ratings
  • 3 hold ratings
  • 0 sell ratings
7/10/2021
  • 0 strong buy ratings
  • 6 buy ratings
  • 4 hold ratings
  • 0 sell ratings
10/8/2021
  • 0 strong buy ratings
  • 6 buy ratings
  • 6 hold ratings
  • 0 sell ratings
1/6/2022
  • 0 strong buy ratings
  • 6 buy ratings
  • 6 hold ratings
  • 0 sell ratings
4/6/2022
  • 0 strong buy ratings
  • 5 buy ratings
  • 6 hold ratings
  • 0 sell ratings
6/5/2022
  • 0 strong buy ratings
  • 5 buy ratings
  • 6 hold ratings
  • 0 sell ratings
7/5/2022

Latest Recommendations

  • 0 strong buy ratings
  • 5 buy ratings
  • 6 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
6/29/2022Wells Fargo & CompanyLower Price TargetEqual Weight$65.00 ➝ $58.00Low
6/2/2022CowenLower Price TargetMarket Perform$80.00 ➝ $70.00Medium
6/2/2022CowenLower Price Target$80.00 ➝ $70.00High
5/31/2022Morgan StanleyLower Price TargetEqual Weight$67.00 ➝ $64.00High
4/7/2022Morgan StanleyLower Price TargetEqual Weight$76.00 ➝ $70.00Medium
3/17/2022ArgusUpgradeHold ➝ Buy$68.00Medium
3/14/2022BarclaysUpgradeEqual Weight ➝ Overweight$75.00Low
2/7/2022Morgan StanleyLower Price TargetEqual Weight$82.00 ➝ $76.00Low
2/4/2022Credit Suisse GroupLower Price TargetOutperform$90.00 ➝ $88.00Low
2/4/2022JPMorgan Chase & Co.Lower Price Target$98.00 ➝ $95.00Medium
2/4/2022Robert W. BairdLower Price Target$86.00 ➝ $81.00Medium
2/4/2022CitigroupLower Price Target$99.00 ➝ $91.00Medium
1/4/2022BarclaysBoost Price TargetEqual Weight$75.00 ➝ $76.00Medium
1/3/2022Vertical ResearchDowngradeBuy ➝ Hold$82.00High
12/16/2021MizuhoInitiated CoverageNeutral$82.00High
11/22/2021Loop CapitalInitiated CoverageBuy$90.00Low
10/29/2021Morgan StanleyBoost Price TargetEqual Weight$78.00 ➝ $82.00High
10/29/2021Royal Bank of CanadaBoost Price TargetSector Perform$75.00 ➝ $77.00High
10/29/2021Credit Suisse GroupBoost Price TargetOutperform$84.00 ➝ $87.00High
10/7/2021Wells Fargo & CompanyInitiated CoverageEqual Weight$72.00Low
7/30/2021Morgan StanleyLower Price TargetEqual Weight$81.00 ➝ $78.00Low
7/30/2021Royal Bank of CanadaLower Price TargetSector Perform$78.00 ➝ $74.00Medium
7/12/2021Wolfe ResearchUpgradePeer Perform ➝ Outperform$81.00 ➝ $84.00Low
5/20/2021Credit Suisse GroupLower Price TargetOutperform$81.00 ➝ $80.00Low
5/20/2021Royal Bank of CanadaLower Price TargetNeutral ➝ Sector Perform$79.00 ➝ $75.00Medium
5/20/2021JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight$70.00 ➝ $80.00Medium
5/4/2021Rosenblatt SecuritiesBoost Price TargetNeutral$71.00 ➝ $72.00Low
4/30/2021Morgan StanleyBoost Price TargetEqual Weight$76.00 ➝ $81.00High
4/12/2021Morgan StanleyBoost Price TargetEqual Weight$75.00 ➝ $76.00High
4/6/2021BarclaysBoost Price TargetEqual Weight$72.00 ➝ $73.00Medium
2/17/2021Morgan StanleyDowngradeOverweight ➝ Equal Weight$75.00 ➝ $75.00Low
2/5/2021CitigroupBoost Price TargetBuy$83.00 ➝ $85.00Medium
1/20/2021Morgan StanleyBoost Price TargetOverweight$74.00 ➝ $75.00Low
12/8/2020Wolfe ResearchDowngradeOutperform ➝ Peer Perform$71.00 ➝ $78.00Medium
12/4/2020UBS GroupInitiated CoverageBuy$83.00High
11/30/2020BarclaysDowngradeOverweight ➝ Equal Weight$72.00High
11/12/2020Royal Bank of CanadaLower Price TargetSector Perform$70.00 ➝ $67.00Low
10/29/2020Rosenblatt SecuritiesBoost Price TargetNeutral$68.00 ➝ $71.00Low
10/28/2020Credit Suisse GroupLower Price TargetOutperform$74.00 ➝ $70.00Low
10/28/2020Morgan StanleyLower Price TargetOverweight$75.00 ➝ $74.00Medium
10/19/2020Rosenblatt SecuritiesLower Price TargetNeutral$81.00 ➝ $68.00Low
10/16/2020Morgan StanleyLower Price TargetOverweight$88.00 ➝ $75.00Low
10/14/2020Credit Suisse GroupLower Price TargetOutperform$89.00 ➝ $74.00Low
10/7/2020JPMorgan Chase & Co.Boost Price TargetNeutral$78.00 ➝ $81.00Medium
10/6/2020CSFBBoost Price TargetOutperform$85.00 ➝ $89.00Low
10/6/2020Credit Suisse GroupBoost Price TargetOutperform$85.00 ➝ $89.00Low
10/6/2020CitigroupBoost Price TargetBuy$84.00 ➝ $91.00Low
9/29/2020Morgan StanleyBoost Price TargetOverweight$83.00 ➝ $88.00Low
9/10/2020BarclaysReiterated RatingBuy$90.00Medium
9/10/2020Bank of AmericaBoost Price TargetBuy$82.00 ➝ $85.00Low
9/10/2020Rosenblatt SecuritiesBoost Price TargetNeutral$79.00 ➝ $81.00Medium
9/10/2020Credit Suisse GroupBoost Price TargetOutperform$82.00 ➝ $85.00Medium
9/2/2020Rosenblatt SecuritiesBoost Price TargetNeutral$77.00 ➝ $79.00Low
7/30/2020Royal Bank of CanadaReiterated RatingHold$74.00Medium
7/29/2020Credit Suisse GroupBoost Price TargetOutperform$76.00 ➝ $82.00High
7/29/2020BarclaysBoost Price TargetOverweight$83.00 ➝ $86.00Medium
7/29/2020Rosenblatt SecuritiesBoost Price TargetHold ➝ Neutral$68.00 ➝ $77.00High
7/20/2020Royal Bank of CanadaReiterated RatingHold$69.00High
6/25/2020Robert W. BairdUpgradeNeutral ➝ Outperform$80.00Medium
6/19/2020Morgan StanleyBoost Price TargetOverweight$72.00 ➝ $83.00Medium
6/5/2020Vertical ResearchUpgradeHold ➝ Buy$75.00High
5/19/2020Morgan StanleyInitiated CoverageOverweight$72.00Low
5/6/2020Credit Suisse GroupLower Price TargetMarket Perform ➝ Outperform$85.00 ➝ $71.00Low
4/28/2020Robert W. BairdLower Price TargetNeutral$81.00 ➝ $70.00Low
4/27/2020CitigroupInitiated CoverageBuy$84.00 ➝ $70.00High
4/17/2020BarclaysReiterated RatingBuy$73.00High
3/9/2020CowenUpgradeUnderperform ➝ Market Perform$70.00High
2/25/2020Rosenblatt SecuritiesReiterated RatingHold$78.00High
2/11/2020Raymond JamesDowngradeOutperform ➝ Market PerformLow
2/3/2020Rosenblatt SecuritiesReiterated RatingHold$77.00Low
1/9/2020Wolfe ResearchUpgradePeer Perform ➝ OutperformLow
12/18/2019Royal Bank of CanadaReiterated RatingHold$79.00Low
12/11/2019Rosenblatt SecuritiesReiterated RatingHold$77.00Medium
12/11/2019Morgan StanleyUpgradeEqual Weight ➝ Overweight$70.00 ➝ $91.00Low
12/9/2019Credit Suisse GroupUpgradeNeutral ➝ Outperform$82.00Low
12/9/2019CitigroupUpgradeNeutral ➝ Buy$76.00 ➝ $84.00Low
11/17/2019Rosenblatt SecuritiesReiterated RatingHold$77.00Low
11/15/2019JPMorgan Chase & Co.Initiated CoverageNeutral$72.00Medium
11/7/2019Rosenblatt SecuritiesInitiated CoverageNeutral$77.00Low
10/28/2019ArgusDowngradeBuy ➝ HoldMedium
10/25/2019Royal Bank of CanadaSet Price TargetHold$73.00N/A
10/25/2019Credit Suisse GroupBoost Price TargetNeutral$73.00 ➝ $75.00Medium
10/15/2019CitigroupLower Price TargetNeutral$86.00 ➝ $76.00High
10/11/2019Morgan StanleyLower Price TargetEqual Weight$85.00 ➝ $70.00Low
9/18/2019Berenberg BankSet Price TargetBuy$86.00Low
9/10/2019Credit Suisse GroupReiterated RatingHold$76.00Low
9/5/2019BarclaysLower Price TargetOverweight$89.00 ➝ $84.00High
9/5/2019Bank of AmericaLower Price TargetBuy$85.00 ➝ $80.00High
8/5/2019Gordon HaskettDowngradeBuy ➝ HoldHigh
7/26/2019Raymond JamesSet Price TargetOutperform$88.00 ➝ $84.00Low
6/3/2019CowenDowngradeMarket Perform ➝ Underperform$75.00 ➝ $65.00Low
5/15/2019Berenberg BankInitiated CoverageBuy ➝ Buy$96.00Low
5/8/2019Morgan StanleyDowngradeOverweight ➝ Equal Weight$83.48Medium
4/30/2019ArgusReiterated RatingBuyLow
4/26/2019BMO Capital MarketsBoost Price TargetOutperform ➝ Outperform$96.00 ➝ $99.00Medium
4/3/2019BarclaysBoost Price TargetOverweight ➝ Overweight$81.00 ➝ $88.00Low
2/12/2019William BlairReiterated RatingMarket PerformMedium
1/3/2019Credit Suisse GroupReiterated RatingNeutral$86.00 ➝ $78.00High
12/18/2018Morgan StanleyUpgradeEqual Weight ➝ Overweight$84.00 ➝ $82.00Low
11/21/2018Royal Bank of CanadaReiterated RatingHold$74.00Low
10/30/2018Morgan StanleyLower Price TargetEqual Weight ➝ Hold$90.00 ➝ $84.00Low
10/29/2018SunTrust BanksLower Price TargetBuy ➝ Buy$92.00 ➝ $85.00Low
10/26/2018Credit Suisse GroupLower Price TargetNeutral ➝ Neutral$89.00 ➝ $86.00High
10/12/2018Credit Suisse GroupInitiated CoverageNeutral$89.00Low
10/12/2018Gordon HaskettInitiated CoverageBuyLow
10/2/2018Morgan StanleySet Price TargetEqual Weight ➝ Equal Weight$90.00Medium
9/13/2018ArgusBoost Price TargetBuy$94.00Medium
9/4/2018Wolfe ResearchDowngradeOutperform ➝ Peer PerformLow
8/30/2018UBS GroupBoost Price TargetBuy ➝ Buy$86.00 ➝ $93.00Low
8/14/2018ArgusBoost Price TargetBuy ➝ Buy$84.00 ➝ $88.00Low
7/31/2018Morgan StanleyBoost Price TargetEqual Weight ➝ Equal Weight$80.00 ➝ $85.00Medium
7/30/2018CitigroupBoost Price TargetNeutral ➝ Neutral$80.00 ➝ $84.00Low
7/27/2018BMO Capital MarketsBoost Price TargetOutperform ➝ Outperform$88.00 ➝ $90.00Low
6/27/2018Wolfe ResearchInitiated CoverageOutperformMedium
3/9/2018JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$84.00High
2/15/2018BarclaysInitiated CoverageOverweight ➝ Overweight$86.00Low
2/12/2018JPMorgan Chase & Co.Boost Price TargetOverweight ➝ Overweight$82.00 ➝ $84.00High
2/9/2018BMO Capital MarketsLower Price TargetOutperform ➝ Outperform$88.00 ➝ $87.00High
2/9/2018Royal Bank of CanadaReiterated RatingNeutral ➝ HoldHigh
2/9/2018CitigroupBoost Price TargetNeutral ➝ Neutral$76.00 ➝ $79.00High
1/26/2018BMO Capital MarketsReiterated RatingBuy$88.00High
1/22/2018UBS GroupInitiated CoverageBuyMedium
1/4/2018Royal Bank of CanadaReiterated RatingHold$79.00Medium
12/1/2017ArgusUpgradeHold ➝ BuyLow
11/15/2017BMO Capital MarketsInitiated CoverageOutperform$82.00N/A
10/27/2017SunTrust BanksReiterated RatingBuy$81.00N/A
10/27/2017CitigroupBoost Price TargetNeutral$72.00 ➝ $74.00N/A
10/27/2017Stifel NicolausBoost Price TargetHold$62.00 ➝ $72.00N/A
10/11/2017Royal Bank of CanadaReiterated RatingHold$70.00N/A
10/9/2017CitigroupReiterated RatingNeutral$65.00 ➝ $72.00N/A
10/2/2017Morgan StanleyReiterated RatingEqual Weight$71.00 ➝ $72.00Low
9/15/2017Royal Bank of CanadaReiterated RatingHold$66.00Low
7/30/2017Royal Bank of CanadaReiterated RatingSector Perform$65.00 ➝ $66.00Low
7/30/2017Stifel NicolausReiterated RatingHold$62.00Low
7/11/2017Morgan StanleyReiterated RatingEqual WeightLow
(Data available from 7/5/2017 forward)

News Sentiment Rating

0.37 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 4 very positive mentions
  • 22 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
12/7/2021
  • 5 very positive mentions
  • 12 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
1/6/2022
  • 1 very positive mentions
  • 17 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
2/5/2022
  • 4 very positive mentions
  • 28 positive mentions
  • 5 negative mentions
  • 1 very negative mentions
3/7/2022
  • 2 very positive mentions
  • 6 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
4/6/2022
  • 6 very positive mentions
  • 31 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
5/6/2022
  • 2 very positive mentions
  • 29 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
6/5/2022
  • 3 very positive mentions
  • 9 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
7/5/2022

Current Sentiment

  • 3 very positive mentions
  • 9 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Fortive logo
Fortive Corporation designs, develops, manufactures, markets, and services professional and engineered products, software, and services worldwide. Its Intelligent Operating Solutions segment offers connected reliability tools; environment, health, safety, and quality enterprise software products; facility and asset lifecycle software; pre-construction planning and construction procurement solutions; ruggedized professional test tools; electric, pressure, and temperature calibration tools; and portable gas detection tools for a range of vertical end markets including manufacturing, process industries, healthcare, utilities and power, communications and electronics, and others. It markets its products and services under the ACCRUENT, FLUKE, GORDIAN, INDUSTRIAL SCIENTIFIC, INTELEX, PRUFTECHNIK, and SERVICECHANNEL brands. The company's Precision Technologies segment provides electrical test and measurement instruments and services; energetic material devices; and sensor and control system solutions for power and energy, medical equipment, food and beverage, aerospace and defense, off-highway vehicles, electronics, semiconductors, and other general industrial markets. This segment markets its products under the ANDERSON-NEGELE, GEMS, SETRA, HENGSTLER-DYNAPAR, QUALITROL, PACIFIC SCIENTIFIC, KEITHLEY, and TEKTRONIX brands. Its Advanced Healthcare Solutions segment offers hardware and software products and services, including instrument and device reprocessing, instrument tracking, biomedical test tools, radiation safety monitoring, and asset management services; subscription-based surgical inventory management systems to facilitate inventory management and regulatory compliance, as well as technical, analytical, and compliance services to determine radiation exposure services under the ASP, CENSIS, CENSITRAC, EVOTECH, FLUKE BIOMEDICAL, INVETECH, LANDAUER, RAYSAFE, and STERRAD brands. Fortive Corporation was incorporated in 2015 and is headquartered in Everett, Washington.
Read More

Today's Range

Now: $54.92
Low: $53.20
High: $55.02

50 Day Range

MA: $58.30
Low: $53.56
High: $63.67

52 Week Range

Now: $54.92
Low: $53.05
High: $79.87

Volume

1,620,135 shs

Average Volume

3,040,400 shs

Market Capitalization

$19.69 billion

P/E Ratio

30.51

Dividend Yield

0.51%

Beta

1.11

Frequently Asked Questions

What sell-side analysts currently cover shares of Fortive?

The following equities research analysts have issued stock ratings on Fortive in the last twelve months: Argus, Barclays PLC, Citigroup Inc., Cowen Inc, Cowen Inc., Credit Suisse Group AG, JPMorgan Chase & Co., Loop Capital, Mizuho, Morgan Stanley, Robert W. Baird, Royal Bank of Canada, StockNews.com, TheStreet, Vertical Research, Wells Fargo & Company, and Wolfe Research.
View the latest analyst ratings for FTV.

What is the current price target for Fortive?

0 Wall Street analysts have set twelve-month price targets for Fortive in the last year. Their average twelve-month price target is $78.33, suggesting a possible upside of 42.6%.
View the latest price targets for FTV.

What is the current consensus analyst rating for Fortive?

Fortive currently has 6 hold ratings and 5 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in FTV, but not buy more shares or sell existing shares.
View the latest ratings for FTV.

How do I contact Fortive's investor relations team?

Fortive's physical mailing address is 6920 SEAWAY BLVD., EVERETT WA, 98203. The technology company's listed phone number is (425) 446-5000 and its investor relations email address is [email protected] The official website for Fortive is www.fortive.com. Learn More about contacing Fortive investor relations.